Paradoxical effects of low dose MDMA on latent inhibition in the rat

about

MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.

P2860

Q42465875-6514259C-07CC-4BEA-B010-6219243DD5E4

P2860

Paradoxical effects of low dose MDMA on latent inhibition in the rat

Item

http://www.wikidata.org/entity/Q36615013

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@ast

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@en

type

Item

label

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@ast

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@en

prefLabel

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@ast

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@en

P1476

Paradoxical effects of low dose MDMA on latent inhibition in the rat

@en

P2093

A J D Nelson

http://www.w3.org/2001/XMLSchema#string

C A Marsden

http://www.w3.org/2001/XMLSchema#string

H J Cassaday

http://www.w3.org/2001/XMLSchema#string

K E Thur

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats

Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review.

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.

Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment.

P304

331-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2012.11.012

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233827665

http://www.w3.org/2001/XMLSchema#string

P698

23201353

http://www.w3.org/2001/XMLSchema#string

P932

3574236

http://www.w3.org/2001/XMLSchema#string

Paradoxical effects of low dose MDMA on latent inhibition in the rat

about

P2860

P2860

Paradoxical effects of low dose MDMA on latent inhibition in the rat

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932